查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529834

全球动物骨科生物技术市场：市场规模、份额、趋势分析 - 按交付模式、按产品、按动物、按应用、按最终用途、按地区、细分市场预测，2024-2030 年

Veterinary Orthobiologics Market Size, Share & Trends Analysis Report By Mode of Delivery (Intra-muscular/Intra-lesional, Intra-articular), By Product, By Animal, By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

动物骨科生物技术市场成长与趋势：

预计2030年全球动物骨科生物技术市场规模将达12.4亿美元，2024年至2030年复合年增长率为8.82%。

推动市场成长的两个关键因素是骨科生物技术临床试验数量的增加和动物整形外科併发症盛行率的上升。近年来，该行业用于治疗兽医整形外科併发症的新型骨科生物製药的临床试验稳步增加。例如，2024年6月，美国FDA核准在狗和马身上启动干细胞临床试验。此临床试验将由康乃尔大学动物医院（CUHA）进行。这项研究探讨了干细胞在治疗狗和马的神经和肌肉骨骼併发症的有效性。研究将从参与者的同基因脂肪或骨髓中提取间质干细胞，并用它们来治疗神经、肌肉和其他疾病。

这项研究收集的资料将有助于兽医再生医学临床实证产品的开发。此外，细胞治疗工具也于2024年6月开始临床试验。在临床前研究中，该公司的产品 ClondroShield 对参与的狗反应良好，显示 OA 得到改善，且没有副作用。这一最新的临床试验阶段旨在招募更多的犬类参与者进行进一步的试验。该产品利用狗血小板内的细胞激素和生长因子来触发受影响区域的癒合反应并帮助修復软骨。这种持续的进步表明市场正在不断发展并带来许多成长机会。此类研究正在帮助开发基于经过彻底审查的证据来治疗整形外科疾病的新产品，为市场提供了显着的成长前景。

此外，整形外科疾病在世界各地的动物中变得越来越常见。例如，在 2024 年发表在 Plos One 上的一项研究中，几位研究人员合作启动了“狗老化计划”，并成功绘製和了解了狗整个生命週期的疾病模式。该计划发现，如果不及时治疗，整形外科疾病的盛行率会随着狗的年龄增加而增加。此外，体重30公斤或以上的狗整形外科疾病盛行率较高（23%），显示肥胖与整形外科疾病之间存在相关性。此外，根据 NCBI 2023 年发表的一篇论文，猫骨关节炎 (OA) 的盛行率估计约为 60%。据报道，被诊断患有骨关节炎的人会出现关节疼痛、关节畸形和跛行等相关症状。事实证明，这些症状在超重的猫中更为常见。所有这些因素意味着需要适当的生物製药，如干细胞、富血小板血浆 (PRP) 和单株抗体 (mAb) 来治疗越来越多的动物整形外科併发症。

动物骨科生物技术市场报告亮点

  • 2023 年，PRP 产品部门的收益占有率最大，为 39.2%。在动物中，血小板对于免疫反应、血管生成和组织修復等多种过程至关重要。 PRP 用于促进血液凝固的癒合过程，因为它含有蛋白质和生长因子，可透过加速新组织的生长来加速肌腱和韧带的癒合。
  • 犬科动物细分市场的特征是采用率高、狗运动相关损伤病例增加、狗骨关节炎患病率高（40%）以及五分之一的狗跛行（Zoetis，2024 年资料），2023 年，该领域占主导地位。
  • 由于狗、猫和马的 OA 盛行率较高以及 OA 的影响因素不断增加，OA 应用领域将在 2023 年以超过 60% 的份额占据市场主导地位。 OA 正成为动物最常见的疾病之一。 OA的主要致病因素包括肥胖、品种、缺乏运动和适当饮食以及遗传倾向。
  • 2023年，市场将由关节内给药模式细分市场主导。这一优势是由于其高需求，因为直接关节内给药可以实现更快的作用并提高药物的生物有效性。在兽医学中，关节内施用关节生物製药是治疗关节疼痛和跛行的既定方法。
  • 根据最终用途，由于在兽医诊所接受动物整形外科疾病治疗的患者数量不断增加，兽医诊所细分市场将在 2023 年占据市场份额主导地位。在需要时，特定的设备和熟练的人员对于管理生物製药至关重要。总体而言，在医院药房的一个地方获得治疗方法、熟练的员工和专业设备对动物饲主来说是一项优势。
  • 北美地区占比最大，2023年为43.23%。这一优势是由于宠物拥有量高、饲主对动物健康的认识高、动物健康支出增加以及 Zoetis、VetStem Inc.、Enso Discovery 和 Ardent Animal Health 等大公司的存在。
  • 由于日本、中国和印度等主要国家研发活动的独创性不断增强，亚太市场预计从 2024 年到 2030 年将以超过 10.09% 的最高复合年增长率成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章动物骨科生物技术市场波动趋势及范围

  • 市场体系展望
  • 市场动态
  • 动物骨科生物技术市场分析工具

第四章动物骨科生物技术市场：产品评估与趋势分析

  • 细分仪表板
  • 动物骨科生物技术市场：产品变异分析
  • 2018-2030年动物骨科生物技术市场规模与趋势分析（依产品）
  • 干细胞
  • 富血小板血浆 (PRP)
  • 其他生技药品

第五章动物骨科生物技术市场：动物估计与趋势分析

  • 细分仪表板
  • 动物骨科生物技术市场：动物变异分析
  • 2018-2030年动物骨科生物技术市场规模与趋势分析（依动物）
  • 狗
  • 马
  • 其他的

第六章动物骨科生物技术市场：应用估算与趋势分析

  • 细分仪表板
  • 动物骨科生物技术市场：应用变化分析
  • 2018-2030年动物骨科生物技术市场规模与趋势分析（按应用）
  • 骨关节炎
  • 骨关节炎
  • 其他用途

第七章动物骨科生物技术市场：交付模式的估计和趋势分析

  • 细分仪表板
  • 动物骨科生物技术市场：分娩方式的变化分析
  • 2018-2030年动物骨科生物技术市场规模及趋势分析（依交付模式）

第八章动物骨科生物技术市场：最终用途估计和趋势分析

  • 细分仪表板
  • 动物骨科生物技术市场：最终用途变化分析
  • 2018-2030 年动物骨科生物技术市场规模与趋势分析（依最终用途）

第九章动物骨科生物技术市场：区域估计和趋势分析

  • 区域仪表板
  • 2023 年和 2030 年按地区分類的动物骨科生物技术市场占有率，百万美元
  • 区域展望
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争格局

  • 市场参与企业分类
  • 企业市场分析/堆图分析
  • 公司简介
    • Zoetis
    • Boehringer Ingelheim
    • Ardent Animal Health Llc.
    • Enso Discoveries
    • VetStem Inc.
    • Medrego Llc
    • T-Cyte Therapeutics
    • Arthrex Inc.
    • Hilltop Bio
    • Enovis
    • Movora
    • Dechra Pharmaceuticals Llc.
  • 策略规划
    • 併购
    • 伙伴关係与协作
    • 扩张
    • 产品发布
    • 产品核可
    • 其他的
  • 主要企业名单
  • 製造商清单
    • 经销商名单
Product Code: GVR-4-68040-369-5

Veterinary Orthobiologics Market Growth & Trends:

The global veterinary orthobiologics market size is expected to reach USD 1.24 billion by 2030, registering a CAGR of 8.82% from 2024 to 2030, according to a new report by Grand View Research, Inc. Two crucial factors driving the market growth are the increasing number of clinical trials in orthobiologics and the rising prevalence of orthopedic complications in animals. The industry has experienced a steady rise in clinical trials for novel orthobiologics in treating veterinary orthopedic complications in recent years. For instance, in June 2024, the U.S. FDA approved initiating stem cell clinical trials for dogs & horses. This trial will be conducted by Cornell University Hospital for Animals (CUHA). It will explore the effectiveness of stem cells in treating neurological and musculoskeletal complications in canine & equine species. The study will extract the participants' allogenic adipose or bone marrow-derived mesenchymal stem cells and use them to treat nerve, muscle, and other conditions.

The data gathered from this study will help develop clinical evidence-based products in veterinary regenerative medicine. Furthermore, Cell Therapy Tools initiated another clinical trial in June 2024. In the pre-clinical studies, the company's product, Chrondroshield, the participants' dogs responded well to the therapy, showing improvements in OA without side effects. This latest clinical trial phase aims to recruit more canine participants for further testing. This product uses cytokine and growth factors inside the dog's platelets to trigger a healing response in the affected area and assist in cartilage repair. These ongoing advancements showcase the market's ever-evolving nature, with many growth opportunities. Studies like these help create novel products for treating orthopedic conditions with a thoroughly scrutinized base of evidence, providing the market with substantial growth prospects.

In addition, throughout the globe, orthopedic conditions are becoming increasingly common in animals. For instance, according to a 2024 Plos One published study, multiple researchers collaborated to initiate a "Dog Aging Project" to map out and understand disease patterns in dogs throughout their lives. The project determined that the prevalence of orthopedic conditions, if left untreated, increases as the age of the dogs progresses, i.e., prevalence at age 1 - 1% and prevalence at age 11 & above - 39%. The dogs with higher weight, i.e., more than 30 kgs, were determined to have a higher prevalence of orthopedic conditions (23%), thus establishing a correlation between obesity and orthopedic diseases. Furthermore, according to a 2023 publication in NCBI, the prevalence of Osteoarthritis (OA) in cats was estimated at around 60%. Those diagnosed with OA were reported to be suffering from associated conditions, such as joint pain, joint deformity, lameness, etc. These symptoms were determined to be on the higher side in overweight cats. All these factors collectively point toward the need for appropriate orthobiologics like stem cells, platelet-rich plasma (PRP), and monoclonal antibody (mAb) to treat this rise in orthopedic complications in animals.

Veterinary Orthobiologics Market Report Highlights:

  • The PRP product segment accounted for the largest revenue share of 39.2% in 2023. In animals, platelets are vital in multiple processes, such as immune response, angiogenesis, and tissue repair. PRP is employed to promote the healing process in blood clotting as it contains proteins & growth factors that speed up the healing of the tendons & ligaments by speeding up the growth of new tissues
  • The canine animal segment dominated the market with a share of 46.1% in 2023 due to the high adoption rate, rising cases of sports-related injuries in dogs, and high prevalence of OA in dogs (40%) and lameness in 1 in 5 dogs (Zoetis, 2024 data)
  • The OA application segment dominated the market with a share of over 60% in 2023 because of the high prevalence of OA and rise in contributing factors to OA in dogs, cats, and horses. OA is becoming one of the most prevalent conditions in animals. The main causative factors for OA can be obesity, breed, lack of exercise & proper diet, and genetic predisposition
  • The intra-articular delivery mode segment dominated the market in 2023. This dominance can be attributed to its demand as it can be directly delivered into the joint to ensure faster action and increase drug bioavailability. In veterinary medicine, intra-articular administration of orthobiologics is an established process for managing joint pain and lameness
  • Based on the end use, the veterinary hospitals segment dominated the market in terms of share in 2023 due to the increased number of patients receiving treatment for orthopedic medical conditions in animals at these hospitals. To administer orthobiologics at the necessary location, specific equipment and skilled staff are essential. Overall, the availability of therapies, skilled personnel, and specialized equipment at the hospital pharmacy in a single location is advantageous to animal owners
  • North America accounted for the largest share of 43.23% in 2023. This dominance can be attributed to the high pet adoption rate, higher animal health awareness among owners, rising spending on animal health, and the presence of major companies, such as Zoetis, VetStem Inc., Enso Discoveries, and Ardent Animal Health
  • The Asia Pacific APAC regional market is expected to grow at the highest CAGR of over 10.09% from 2024 to 2030 due to increasing ingenuity in R&D activities in major countries like Japan, China, and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Orthobiologics Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advances in Veterinary Regenerative Medicine
      • 3.2.1.2. Rising Prevalence of Orthopedic Complications in Animals
      • 3.2.1.3. Global Rise in Animal Athletic Events
      • 3.2.1.4. Rising Innovative Product Launches
      • 3.2.1.5. Increasing Number of Clinical Trials
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Underdiagnosis of Orthopedic Complications
      • 3.2.2.2. Misleading Practices by Industry Players
      • 3.2.2.3. Product Limitations
      • 3.2.2.4. Lack of Clinical Evidence
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Orthobiologics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Estimated Animal Population, by Key Species, by Key Countries, 2018-2023
    • 3.3.5. Clinical Trials Analysis
    • 3.3.6. Pricing Analysis
    • 3.3.7. COVID-19 Impact Analysis

Chapter 4. Veterinary Orthobiologics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Orthobiologics Market: Product Movement Analysis
  • 4.3. Veterinary Orthobiologics Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
  • 4.4. Stem Cells
    • 4.4.1. Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Platelet-Rich Plasma (PRP)
    • 4.5.1. Platelet-Rich Plasma (PRP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Other Biologics
    • 4.6.1. Other Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Orthobiologics Market: Animal Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Orthobiologics Market: Animal Movement Analysis
  • 5.3. Veterinary Orthobiologics Market Size & Trend Analysis, by animal, 2018 to 2030 (USD Million)
  • 5.4. Canine
    • 5.4.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Equine
    • 5.5.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Orthobiologics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Orthobiologics Market: Application Movement Analysis
  • 6.3. Veterinary Orthobiologics Market Size & Trend Analysis, by application, 2018 to 2030 (USD Million)
  • 6.4. Osteoarthritis
    • 6.4.1. Osteoarthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Degenerative Joint Disease
    • 6.5.1. Degenerative Joint Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Orthobiologics Market: By Mode of Delivery Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Orthobiologics Market: By Mode of Delivery Movement Analysis
  • 7.3. Veterinary Orthobiologics Market Size & Trend Analysis, by mode of delivery, 2018 to 2030 (USD Million)
    • 7.3.1. Intra-muscular/Intra-lesional
      • 7.3.1.1. Intra-muscular/Intra-lesional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Intra-articular
      • 7.3.2.1. Intra-articular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Other Modes
      • 7.3.3.1. Other Modes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Orthobiologics Market: By End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Veterinary Orthobiologics Market: By End Use Movement Analysis
  • 8.3. Veterinary Orthobiologics Market Size & Trend Analysis, by end use, 2018 to 2030 (USD Million)
    • 8.3.1. Veterinary Hospitals
      • 8.3.1.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. Veterinary Clinics
      • 8.3.2.1. Veterinary Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Others
      • 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Veterinary Orthobiologics Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Veterinary Orthobiologics Market Share, By Region, 2023 & 2030, USD Million
  • 9.3. Regional Outlook
  • 9.4. North America
    • 9.4.1. North America Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competition Insights
      • 9.4.2.3. U.S. Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competition Insights
      • 9.4.3.3. Canada Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competition Insights
      • 9.4.4.3. Mexico Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competition Insights
      • 9.5.2.3. UK Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competition Insights
      • 9.5.3.3. Germany Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competition Insights
      • 9.5.4.3. France Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competition Insights
      • 9.5.5.3. Italy Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competition Insights
      • 9.5.6.3. Spain Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. Denmark
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competition Insights
      • 9.5.7.3. Denmark Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Competition Insights
      • 9.5.8.3. Sweden Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.9. Norway
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Competition Insights
      • 9.5.9.3. Norway Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competition Insights
      • 9.6.2.3. Japan Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competition Insights
      • 9.6.3.3. China Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competition Insights
      • 9.6.4.3. India Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Competition Insights
      • 9.6.5.3. Australia Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Competition Insights
      • 9.6.6.3. South Korea Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Competition Insights
      • 9.6.7.3. Thailand Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competition Insights
      • 9.7.2.3. Brazil Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competition Insights
      • 9.7.3.3. Argentina Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8. Middle East & Africa
    • 9.8.1. Middle East & Africa Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Competition Insights
      • 9.8.2.3. South Africa Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Competition Insights
      • 9.8.3.3. Saudi Arabia Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Competition Insights
      • 9.8.4.3. UAE Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Competition Insights
      • 9.8.5.3. Kuwait Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Company Market Position Analysis/ Heap Map Analysis
  • 10.3. Company Profiles
    • 10.3.1. Zoetis
      • 10.3.1.1. Participant's Overview
      • 10.3.1.2. Financial Performance
      • 10.3.1.3. Product Benchmarking
      • 10.3.1.4. Strategic Initiatives
    • 10.3.2. Boehringer Ingelheim
      • 10.3.2.1. Participant's Overview
      • 10.3.2.2. Financial Performance
      • 10.3.2.3. Product Benchmarking
      • 10.3.2.4. Strategic Initiatives
    • 10.3.3. Ardent Animal Health Llc.
      • 10.3.3.1. Participant's Overview
      • 10.3.3.2. Financial Performance
      • 10.3.3.3. Product Benchmarking
      • 10.3.3.4. Strategic Initiatives
    • 10.3.4. Enso Discoveries
      • 10.3.4.1. Participant's Overview
      • 10.3.4.2. Financial Performance
      • 10.3.4.3. Product Benchmarking
      • 10.3.4.4. Strategic Initiatives
    • 10.3.5. VetStem Inc.
      • 10.3.5.1. Participant's Overview
      • 10.3.5.2. Financial Performance
      • 10.3.5.3. Product Benchmarking
      • 10.3.5.4. Strategic Initiatives
    • 10.3.6. Medrego Llc
      • 10.3.6.1. Participant's Overview
      • 10.3.6.2. Financial Performance
      • 10.3.6.3. Product Benchmarking
      • 10.3.6.4. Strategic Initiatives
    • 10.3.7. T-Cyte Therapeutics
      • 10.3.7.1. Participant's Overview
      • 10.3.7.2. Financial Performance
      • 10.3.7.3. Product Benchmarking
      • 10.3.7.4. Strategic Initiatives
    • 10.3.8. Arthrex Inc.
      • 10.3.8.1. Participant's Overview
      • 10.3.8.2. Financial Performance
      • 10.3.8.3. Product Benchmarking
      • 10.3.8.4. Strategic Initiatives
    • 10.3.9. Hilltop Bio
      • 10.3.9.1. Participant's Overview
      • 10.3.9.2. Financial Performance
      • 10.3.9.3. Product Benchmarking
      • 10.3.9.4. Strategic Initiatives
    • 10.3.10. Enovis
      • 10.3.10.1. Participant's Overview
      • 10.3.10.2. Financial Performance
      • 10.3.10.3. Product Benchmarking
      • 10.3.10.4. Strategic Initiatives
    • 10.3.11. Movora
      • 10.3.11.1. Participant's Overview
      • 10.3.11.2. Financial Performance
      • 10.3.11.3. Product Benchmarking
      • 10.3.11.4. Strategic Initiatives
    • 10.3.12. Dechra Pharmaceuticals Llc.
      • 10.3.12.1. Participant's Overview
      • 10.3.12.2. Financial Performance
      • 10.3.12.3. Product Benchmarking
      • 10.3.12.4. Strategic Initiatives
  • 10.4. Strategy Mapping
    • 10.4.1. Mergers & Acquisitions
    • 10.4.2. Partnerships & Collaborations
    • 10.4.3. Expansion
    • 10.4.4. Product launch
    • 10.4.5. Product Approval
    • 10.4.6. Others
  • 10.5. List of Key Companies
  • 10.6. List of Manufacturers
    • 10.6.1. List of Distributors

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 Global Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 5 Global Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 6 Global Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 7 Global Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 Global Veterinary Orthobiologics Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 North America Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 12 North America Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 North America Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 14 North America Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 U.S. Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 16 U.S. Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 17 U.S. Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 18 U.S. Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 19 U.S. Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20 Canada Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Canada Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 22 Canada Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Canada Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 24 Canada Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Mexico Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Mexico Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 27 Mexico Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 28 Mexico Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 29 Mexico Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30 Europe Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Europe Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 33 Europe Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 34 Europe Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 35 Europe Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36 Germany Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 37 Germany Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 38 Germany Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Germany Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 40 Germany Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 UK Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 UK Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 43 UK Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 UK Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 45 UK Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 France Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 France Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 48 France Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 France Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 50 France Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51 Italy Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 52 Italy Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 53 Italy Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 Italy Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 55 Italy Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 Spain Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 57 Spain Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 58 Spain Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 59 Spain Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 60 Spain Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 Denmark Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 62 Denmark Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 63 Denmark Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Denmark Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 65 Denmark Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66 Sweden Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 67 Sweden Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 68 Sweden Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 Sweden Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 70 Sweden Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 71 Norway Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 72 Norway Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 73 Norway Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Norway Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 75 Norway Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82 China Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 83 China Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 84 China Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 85 China Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 86 China Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 87 Japan Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 Japan Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 89 Japan Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 Japan Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 91 Japan Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 92 India Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 93 India Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 94 India Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 India Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 96 India Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 97 South Korea Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 98 South Korea Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 99 South Korea Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 100 South Korea Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 101 South Korea Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 102 Australia Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 103 Australia Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 104 Australia Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 105 Australia Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 106 Australia Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 107 Thailand Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 108 Thailand Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 109 Thailand Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 110 Thailand Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 111 Thailand Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 112 Latin America Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
  • Table 113 Latin America Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 114 Latin America Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 115 Latin America Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 116 Latin America Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 117 Latin America Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 118 Brazil Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 119 Brazil Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 120 Brazil Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 121 Brazil Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 122 Brazil Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 123 Argentina Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 124 Argentina Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 125 Argentina Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 126 Argentina Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 127 Argentina Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 134 South Africa Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 135 South Africa Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 136 South Africa Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 137 South Africa Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 138 South Africa Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 144 UAE Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 145 UAE Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 146 UAE Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 147 UAE Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 148 UAE Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Veterinary Orthobiologics Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Veterinary Orthobiologics Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 15 Global Veterinary Orthobiologics Market, for Stem Cells, 2018 - 2030 (USD Million)
  • Fig. 16 Global Veterinary Orthobiologics Market, for Platelet-Rich Plasma (PRP), 2018 - 2030 (USD Million)
  • Fig. 17 Global Veterinary Orthobiologics Market, for Other Biologics, 2018 - 2030 (USD Million)
  • Fig. 18 Global Veterinary Orthobiologics Market, for Animal, 2018 - 2030 (USD Million)
  • Fig. 19 Global Veterinary Orthobiologics Market, for Canine, 2018 - 2030 (USD Million)
  • Fig. 20 Global Veterinary Orthobiologics Market, for Equine, 2018 - 2030 (USD Million)
  • Fig. 21 Global Veterinary Orthobiologics Market, for Other Animals, 2018 - 2030 (USD Million)
  • Fig. 22 Global Veterinary Orthobiologics Market, for Application, 2018 - 2030 (USD Million)
  • Fig. 23 Global Veterinary Orthobiologics Market, for Osteoarthritis, 2018 - 2030 (USD Million)
  • Fig. 24 Global Veterinary Orthobiologics Market, for Degenerative Joint Disease (DJD), 2018 - 2030 (USD Million)
  • Fig. 25 Global Veterinary Orthobiologics Market, for Other Applications, 2018 - 2030 (USD Million)
  • Fig. 26 Global Veterinary Orthobiologics Market, for Mode of Delivery, 2018 - 2030 (USD Million)
  • Fig. 27 Global Veterinary Orthobiologics Market, for Intra-muscular/Intra-lesional, 2018 - 2030 (USD Million)
  • Fig. 28 Global Veterinary Orthobiologics Market, for Intra-articular, 2018 - 2030 (USD Million)
  • Fig. 29 Global Veterinary Orthobiologics Market, for Other Modes, 2018 - 2030 (USD Million)
  • Fig. 30 Global Veterinary Orthobiologics Market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 31 Global Veterinary Orthobiologics Market, for Veterinary Hospitals, 2018 - 2030 (USD Million)
  • Fig. 32 Global Veterinary Orthobiologics Market, for Veterinary Clinics, 2018 - 2030 (USD Million)
  • Fig. 33 Global Veterinary Orthobiologics Market, for Other end-use, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Outlook, 2023 & 2030
  • Fig. 35 North America Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 47 NorwayVeterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)